Allergan acquires Argentine skin care company.IRVINE, Calif.--(BUSINESS WIRE)--Dec. 15, 1994--Allergan Inc. (NYSE NYSE See: New York Stock Exchange :AGN AGN Again (Amateur Radio) AGN Active Galactic Nucleus AGN Acute Glomerulonephritis AGN Accountants Global Network AGN Air Gabon (ICAO code) ) announced that it has acquired Lorsen SA, a skin care company based in Buenos Aires, Argentina. Terms of the agreement were not disclosed. "The acquisition of Lorsen allows us to build a regional base in both the aesthetic and ethical dermatological markets and prepares us for the future launch of the topical retinoid retinoid /ret·i·noid/ (ret´i-noid) 1. resembling the retina. 2. retinal, retinol, or any structurally similar natural derivative or synthetic compound, with or without vitamin A activity. tazarotene for the treatment of psoriasis," said Allergan President and Chief Executive Officer William C. Shepherd. "Coupled with our earlier acquisition of LOA Loa (lō`ä), longest river of Chile, 275 mi (443 km) long, flowing S from the Andes, N Chile, then W and N through the Atacama Desert, before turning W to the Pacific Ocean. , an Argentine ophthalmic pharmaceutical company, Argentina is becoming an important part of our Latin America strategy." Allergan, a global health care company with headquarters in Irvine, develops, manufactures, and markets specialty therapeutic products for eye and skin care and neuromuscular neuromuscular /neu·ro·mus·cu·lar/ (-mus´ku-ler) pertaining to nerves and muscles, or to the relationship between them. neu·ro·mus·cu·lar adj. 1. disorders. A technology-driven company, Allergan is working to be the partner of choice for ever better health care. CONTACT: Allergan Inc., Irvine
Jeff D'Eliscu, 714/752-4636 (work)
or 714/675-9475 (home)
|
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion